logo
Phanes Therapeutics announces first patient dosed in clinical study of mavrostobart (PT199) in combination with chemotherapy

Phanes Therapeutics announces first patient dosed in clinical study of mavrostobart (PT199) in combination with chemotherapy

Yahoo27-05-2025
SAN DIEGO, May 27, 2025 /PRNewswire/ -- Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, announced today that the first patient has been dosed in the clinical study of mavrostobart (PT199) in combination with chemotherapy.
Mavrostobart is an anti-CD73 monoclonal antibody with a differentiated mechanism of action and is designed to counter the adenosine-mediated immunosuppressive tumor microenvironment (TME). Mavrostobart fully inhibits the enzyme activities of both soluble and membrane-bound CD73, unlike several other anti-CD73 antibodies which exhibit incomplete inhibition. Moreover, at higher concentrations, no loss of inhibition or "hook effect" is observed with mavrostobart. Hence, mavrostobart addresses the limitations of current CD73 inhibitors and is expected to increase antitumor immune activation, and potentially offer a new treatment option for cancer patients.
The multi-center Phase I/II clinical trial of mavrostobart (NCT05431270), known as the MORNINGSTAR study, is currently evaluating the safety, tolerability, pharmacokinetics and preliminary efficacy of mavrostobart alone and in combination with a PD-1 Inhibitor or chemotherapy. A Phase I clinical trial of mavrostobart is also ongoing in China (CTR20242381).
ABOUT PHANES THERAPEUTICS
Phanes Therapeutics, Inc. is a clinical stage biotech company focused on innovative drug discovery and development in oncology. Currently, it is conducting three Phase I/II clinical trials, including the MORNINGSTAR study with its best-in-class monoclonal antibody (mAb) program, mavrostobart (PT199), the TWINPEAK study with spevatamig (PT886) and the SKYBRIDGE study with peluntamig (PT217). Both spevatamig and peluntamig are first-in-class bispecific antibodies and have been granted orphan drug designations as well as Fast Track designations by the FDA.
The company has built a strong pipeline by leveraging its proprietary technology platforms: PACbody®, SPECpair® and ATACCbody® to develop novel biologics that address high unmet medical needs in cancer.
For more information about Phanes Therapeutics, please visit www.phanesthera.com
For business development or media inquiries, please contact bd@phanestx.com or media@phanestx.com, respectively.
View original content to download multimedia:https://www.prnewswire.com/news-releases/phanes-therapeutics-announces-first-patient-dosed-in-clinical-study-of-mavrostobart-pt199-in-combination-with-chemotherapy-302464552.html
SOURCE Phanes Therapeutics, Inc.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

From Surviving to Thriving: Igor Wallaert Launches Groundbreaking Health Coaching Program for Hopeless Young Men
From Surviving to Thriving: Igor Wallaert Launches Groundbreaking Health Coaching Program for Hopeless Young Men

Yahoo

time11 minutes ago

  • Yahoo

From Surviving to Thriving: Igor Wallaert Launches Groundbreaking Health Coaching Program for Hopeless Young Men

Igor Wallaert's powerful system guides men from chronic stress to effortless, sustainable health- physically, mentally, and emotionally OSLO, Norway and BRUSSELS, July 28, 2025 /PRNewswire/ -- Certified health coach and wellness strategist Igor Wallaert is set to launch his flagship 16-week program, a revolutionary offering tailored for young single men across Europe who feel stuck in patterns of hopelessness, anger, and chronic emotional and physical fatigue. The program is built around one core mission: to help men transition from survival mode into a lifelong state of thriving, grounded in effortless health and sustainable self-mastery. Rooted in holistic wellness, mindset shifts, and strategic lifestyle changes, the program targets a growing demographic—men who feel emotionally unsupported, stuck in patterns of burnout, and uncertain how to rebuild their lives. Wallaert's structured system combines weekly modules, direct coaching, and practical tools that help rebuild inner discipline, manage reactive emotions, and foster long-term physical and mental resilience. "I wish I had this system when I started my journey," says Wallaert. "This isn't about short-term hacks. It's about creating a foundation that supports you for life." The program's approach aligns with research from Patient Education and Counseling, which highlights how health coaching improves chronic condition management and boosts physical, behavioral, and emotional well-being. Participants in similar programs report better self-esteem, improved social connections, and healthier habits across the board. What sets Wallaert's offering apart is its targeted focus: high-touch, male-focused coaching that recognizes the silent struggles many men carry. "Most men I work with aren't broken," says Wallaert. "They've just been surviving. No one ever taught them how to thrive." This initiative is launching at a time when mental health issues are rising among men, especially in younger age groups. By offering a structured, deeply personal coaching experience, Wallaert hopes to shift the narrative from coping to flourishing. The official program launch is scheduled for late July 2025, with rolling enrollment available via About Igor WallaertIgor Wallaert is a holistic health coach based in Europe, dedicated to helping young men break free from emotional stagnation and physical neglect. Through his 16-week transformation program, he helps clients build sustainable health and inner stability, combining mindset work, strategic action, and proven wellness principles. Media Contact: igorwallaert@ Photo: View original content to download multimedia: SOURCE Igor Daniel G- Wallaert Sign in to access your portfolio

Cloud Computing Stocks in Vogue: 4 Picks to Swim With the Tide
Cloud Computing Stocks in Vogue: 4 Picks to Swim With the Tide

Yahoo

timean hour ago

  • Yahoo

Cloud Computing Stocks in Vogue: 4 Picks to Swim With the Tide

An updated edition of the June 05, 2025 by widespread adoption, cloud computing has generated a significant buzz across the length and breadth of the business enterprise ecosystem. Driving innovation and digital transformation by capitalizing on virtualization technology, it has enabled users to access and store data over the Internet without managing their physical servers and intricate IT infrastructure. This on-demand access to computing resources as services over the Internet ('the cloud' per se) has facilitated the development of cutting-edge technologies. Moreover, by enabling multiple users to share the same hardware resources by connecting to the cloud platform through a web browser or dedicated applications, cloud computing has created the framework for seamless omnichannel customer engagement at lower cloud computing gains traction with greater flexibility and scalability, it has emerged as an attractive theme for investors seeking to invest in blue-chip tech firms. This has made cloud computing companies like Microsoft Corporation MSFT, Inc. AMZN, International Business Machines Corporation IBM and Arista Networks Inc. ANET indispensable for any investment portfolio. But before digging deep into these prized possessions, let us delve a little more into why organizations are increasingly adopting cloud computing eliminates fixed capital expenses pertaining to the purchase of related hardware and software. It reduces the operating costs of maintaining onsite data centers and deploying IT experts to manage the infrastructure, making it highly cost-effective. Based on a pay-per-use pricing model, enterprises only pay for the computing resources they use. With easy access to a plethora of innovative technologies, it increases productivity with greater agility and flexibility, and improves scalability with higher economies of scale. Moreover, cloud computing services are delivered over a highly secure network with low latency for applications and data backup facilities for improved computing services fall into four broad categories, namely infrastructure as a service (IaaS), platform as a service (PaaS), serverless and software as a service (SaaS), offering different levels of control, flexibility and management options to business enterprises. Cloud computing, relying heavily on virtualization and automation technologies, provides the requisite infrastructure for AI (artificial intelligence) and machine learning (ML) workloads. It delivers powerful computing abilities to process and analyze data, creating an ideal platform for Big Data Grand View Research, the global cloud computing market size is expected to swell to $2,390.2 billion by 2030 from $752.4 billion in 2024 at a CAGR of 20.4% with a variety of capabilities across multiple industries. These include better patient monitoring and outcomes in healthcare, personalized financial management and predictive spending, immersive learning in education, superior inventory management in retail and predictive maintenance and better supply chain management in the manufacturing sector. If you intend to capitalize on this buzzing trend, our Cloud Computing Thematic Screen could make it easy to identify high-potential stocks in this domain at any given time, just like the four mentioned above. By leveraging advanced tools, our thematic screens identify companies shaping the future, making it easier to benefit from emerging trends. Ready to uncover more transformative thematic investment ideas? Explore 30 cutting-edge investment themes with and discover your next big opportunity. 4 Cloud Computing Stocks to Keep an Eye on Microsoft is one of the prominent public cloud providers that can deliver a wide variety of IaaS and PaaS solutions at scale. Microsoft Azure, its cloud computing platform, allows users to build, run and scale applications in the cloud. It offers a variety of services, including storage, networking, analytics and AI. Microsoft has doubled down on the cloud computing opportunity. Azure's increased availability in more than 60 announced regions globally has strengthened Microsoft's competitive position in the cloud computing market. Operating through a vast network of global data centers that ensure high availability and reliability for applications, Azure offers seamless access to all the services included in the portal once customers subscribe to it. Subscribers can use these services to create cloud-based resources, such as virtual machines (VMs) and databases, which can then be assembled into running environments used to host workloads and store Microsoft continues to push the boundaries of networking technology, it aims to create innovative, resilient and secure solutions that enable businesses to leverage AI and the cloud to their fullest potential. It is heavily investing in AI-powered cloud services, integrating Azure OpenAI Service, Copilot and ML into various cloud solutions, making AI a central feature of Azure to empower organizations to manage their applications with greater confidence and efficiency. Microsoft carries a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks enjoys a dominant position in the cloud-computing market, particularly in the IaaS space, thanks to Amazon Web Services (AWS), which is one of its high-margin-generating businesses. The expanding customer base of AWS, driven by its strengthening cloud offerings, will continue to aid Amazon's dominance in the global cloud space. AWS is the world's most comprehensive and broadly adopted on-demand cloud computing platform, offering more than 200 fully featured services from data centers globally. Millions of customers, including the fastest-growing startups, largest enterprises and leading government agencies, are using AWS to lower costs, become more agile and innovate faster. It reportedly offers the widest variety of databases that are purpose-built for different types of applications to enable subscribers to choose the right tool for the aims to extend AWS' AI and ML capabilities to facilitate improved decision-making. This Zacks Rank #1 company intends to expand its global infrastructure for faster and more reliable service with low latency and maximum availability. From cloud-native applications and AI-driven solutions to edge computing and sustainability initiatives, AWS is likely to push the limits in the realm of cloud computing has gradually evolved as a provider of cloud and data platforms. The Red Hat acquisition, in particular, has helped it strengthen its competitive position in the hybrid cloud market. With the buyout, the company offers a Linux operating system—Red Hat Enterprise Linux—and a hybrid cloud platform—Red Hat OpenShift—that aids enterprises with digital a surge in traditional cloud-native workloads and associated applications, along with a rise in generative AI deployment, there is a radical expansion in the number of cloud workloads that enterprises are currently managing. This has resulted in heterogeneous, dynamic and complex infrastructure strategies, which have led firms to undertake a cloud-agnostic and interoperable approach to highly secure multi-cloud management. This, in turn, has translated into a healthy demand for IBM hybrid cloud solutions. In addition, the buyout of HashiCorp has significantly augmented IBM's capabilities to assist enterprises in managing complex cloud environments. HashiCorp's tool sets complement IBM RedHat's portfolio, bringing additional functionalities for cloud infrastructure management and bolstering its hybrid multi-cloud approach. IBM is poised to benefit from strong demand for hybrid cloud and AI, driving growth in the Software and Consulting segments. This Zacks Rank #2 company's growth is expected to be aided primarily by analytics, cloud computing and security in the long provides cloud networking solutions for data centers and cloud computing environments. At the core of the company's cloud networking solutions is the Linux-based Extensible Operating System (EOS), which supports leading cloud and virtualization solutions, including Microsoft System Center, OpenStack and other cloud management addition to high capacity and easy availability, its cloud networking solutions promise predictable performance, along with programmability that enables integration with third-party applications for network management, automation and orchestration. Arista provides routing and switching platforms with industry-leading capacity, low latency, port density and power efficiency. The company boasts a multi-domain modern software approach built upon a unique and differentiating foundation, the single EOS and CloudVision stack. The versatility of Arista's unified software stack across various use cases, including WAN routing and campus and data center infrastructure, sets it apart from other competitors in the industry. With customers increasingly deploying transformative cloud networking solutions, the company has announced several additions to its multi-cloud and cloud-native software product family with CloudEOS Edge. This Zacks Rank #1 stock has introduced cognitive Wi-Fi software that delivers intelligent application identification, automated troubleshooting and location services. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Inc. (AMZN) : Free Stock Analysis Report Microsoft Corporation (MSFT) : Free Stock Analysis Report International Business Machines Corporation (IBM) : Free Stock Analysis Report Arista Networks, Inc. (ANET) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio

FTRE Deadline: Rosen Law Firm Urges Fortrea Holdings, Inc. (NASDAQ: FTRE) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
FTRE Deadline: Rosen Law Firm Urges Fortrea Holdings, Inc. (NASDAQ: FTRE) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Business Wire

time2 hours ago

  • Business Wire

FTRE Deadline: Rosen Law Firm Urges Fortrea Holdings, Inc. (NASDAQ: FTRE) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action lawsuit on behalf of purchasers of Fortrea Holdings, Inc. (NASDAQ: FTRE) securities between July 3, 2023 and February 28, 2025. Fortrea is a global contract research organization. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that Fortrea Holdings, Inc. (NASDAQ: FTRE) Misled Investors Regarding its Business Operations. According to the lawsuit, throughout the Class Period, defendants made false and misleading statements and/or failed to disclose that: (1) Fortrea overestimated the amount of revenue the Pre-Spin Projects were likely to contribute to Fortrea's 2025 earnings; (2) Fortrea overstated the cost savings it would likely achieve by exiting the transition service agreements ('TSAs'); (3) as a result, Fortrea's previously announced EBITDA targets for 2025 were inflated; (4) accordingly, the viability of Fortrea's post-Spin-Off business model, as well as its business and/or financial prospects, were overstated; and (5) as a result, Fortrea's public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. What Now: You may be eligible to participate in the class action against Fortrea Holdings, Inc. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by August 1, 2025. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here. All representation is on a contingency fee basis. Shareholders pay no fees or expenses. About Rosen Law Firm: Some law firms issuing releases about this matter do not actually litigate securities class actions. Rosen Law Firm does. Rosen Law Firm is a recognized leader in shareholder rights litigation, dedicated to helping shareholders recover losses, improving corporate governance structures, and holding company executives accountable for their wrongdoing. Since its inception, Rosen Law Firm has obtained over $1 billion for shareholders. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store